Doximity, Inc. (NASDAQ:DOCS) Receives $67.42 Consensus Target Price from Analysts

Doximity, Inc. (NASDAQ:DOCS) has received an average recommendation of “Moderate Buy” from the twenty-two research firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $68.1579.

Several research firms recently weighed in on DOCS. Wells Fargo & Company upped their price target on Doximity from $55.00 to $62.00 and gave the company an “equal weight” rating in a research report on Monday, August 4th. Bank of America lifted their target price on Doximity from $55.00 to $62.00 and gave the company a “neutral” rating in a research note on Wednesday, June 25th. The Goldman Sachs Group set a $64.00 price target on shares of Doximity and gave the stock a “sell” rating in a report on Wednesday. Raymond James Financial set a $75.00 price target on shares of Doximity in a report on Wednesday, September 10th. Finally, Evercore ISI upgraded shares of Doximity from an “in-line” rating to an “outperform” rating and increased their target price for the stock from $50.00 to $70.00 in a research report on Wednesday, July 9th.

Insider Buying and Selling at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the transaction, the director owned 16,618 shares in the company, valued at $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Regina M. Benjamin sold 5,000 shares of the business’s stock in a transaction dated Friday, July 11th. The shares were sold at an average price of $60.04, for a total value of $300,200.00. Following the completion of the transaction, the director owned 16,618 shares in the company, valued at $997,744.72. This trade represents a 23.13% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 37,000 shares of company stock worth $2,581,880 over the last 90 days. 31.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of DOCS. SG Americas Securities LLC acquired a new position in shares of Doximity during the 1st quarter worth $65,702,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Doximity by 130.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock worth $114,133,000 after buying an additional 1,113,076 shares during the last quarter. Franklin Resources Inc. lifted its position in shares of Doximity by 53.9% in the second quarter. Franklin Resources Inc. now owns 3,162,593 shares of the company’s stock worth $193,993,000 after buying an additional 1,108,162 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Doximity by 8.8% in the first quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock worth $707,646,000 after buying an additional 990,923 shares during the last quarter. Finally, Holocene Advisors LP bought a new position in shares of Doximity in the 2nd quarter valued at approximately $44,983,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Price Performance

Doximity stock opened at $73.25 on Friday. The firm’s 50 day simple moving average is $67.25 and its 200-day simple moving average is $60.70. The company has a market cap of $13.72 billion, a P/E ratio of 73.25, a price-to-earnings-growth ratio of 4.10 and a beta of 1.38. Doximity has a fifty-two week low of $40.87 and a fifty-two week high of $85.21.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm’s revenue for the quarter was up 15.2% on a year-over-year basis. During the same period last year, the business posted $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, analysts expect that Doximity will post 0.99 EPS for the current fiscal year.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.